Department of Hematology and Coagulation Disorders, Lund University, Skåne University Hospital, Malmö, Sweden.
Haemophilia. 2013 Mar;19 Suppl 3(0 3):1-18. doi: 10.1111/hae.12078.
The first meeting of international specialists in the field of von Willebrand disease (VWD) was held in the Åland islands in 1998 where Erik von Willebrand had first observed a bleeding disorder in some members of a family from Föglö and a summary of the meeting was published in 1999. The second meeting was held in 2010 and a report of the meeting was published in 2012. Topics covered included progress in understanding of VWD over the last 50 years; multimers; classification of VWD; pharmacokinetics and laboratory assays; genetics; treating the paediatric patient; prophylaxis; geriatrics; gene therapy and treatment guidelines. This third meeting held over 3 days covered the structure and function of von Willebrand factor (VWF); type 1 VWD, the most common form of the disease; a lifespan of pharmacokinetics in VWD; detecting inhibitors in VWD patients; and special challenges in understanding and treating the female VWD patient.
1998 年,国际血管性血友病(VWD)专家首次在奥兰群岛举行会议,Erik von Willebrand 最初在 Föglö 的一些家族成员中观察到出血性疾病,并于 1999 年发表了会议摘要。第二次会议于 2010 年举行,并于 2012 年发表了会议报告。会议涵盖的主题包括过去 50 年来对 VWD 的理解进展;多聚体;VWD 的分类;药代动力学和实验室检测;遗传学;儿科患者的治疗;预防;老年病学;基因治疗和治疗指南。为期三天的第三次会议涵盖了血管性血友病因子(VWF)的结构和功能;最常见的疾病类型 1 型 VWD;VWD 患者的药代动力学寿命;检测 VWD 患者中的抑制剂;以及理解和治疗女性 VWD 患者的特殊挑战。